OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Ming-Ming Zhou

1 Projects | 1 Researchers | $600,621 Invested

2000

Icahn School of Medicine at Mount Sinai

Ming-Ming Zhou, PhD

Structure-based Functional Design of Antagonists for Glutamate Receptors

  • Funding Amount: $600,621
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed